Granules Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GRANULES, and what generic and branded alternatives to GRANULES drugs are available?
GRANULES has sixty-two approved drugs.
There is one tentative approval on GRANULES drugs.
Summary for Granules
US Patents: | 0 |
Tradenames: | 49 |
Ingredients: | 49 |
NDAs: | 62 |
Patent Litigation for Granules: | See patent lawsuits for Granules |
Drugs and US Patents for Granules
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Granules | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 217027-004 | Jan 23, 2023 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Granules | ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077636-001 | Dec 22, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Granules | DOFETILIDE | dofetilide | CAPSULE;ORAL | 212750-002 | Oct 14, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.